TRNS Stock Up 12% after 7-Day Win Streak

TRNS: Transcat logo
TRNS
Transcat

Transcat (TRNS) stock hit day 7 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 12% return. The company has gained about $101 Mil in value over the last 7 days, with its current market capitalization at about $850 Mil. The stock remains 13.8% below its value at the end of 2024. This compares with year-to-date returns of 9.5% for the S&P 500.

TRNS provides calibration, repair, inspection, maintenance, consulting services, and sells or rents test, measurement, and control instruments internationally. After this rally, is TRNS still a buy – or is it time to lock in gains? Deep dive with Buy or Sell TRNS.

Comparing TRNS Stock Returns With The S&P 500

The following table summarizes the return for TRNS stock vs. the S&P 500 index over different periods, including the current streak:
 

Relevant Articles
  1. AST SpaceMobile: Is This Starlink Rival Stock Poised To Soar Higher?
  2. Where Is Alphabet Stock Headed?
  3. How To Earn 8.2% Yield While Waiting to Buy WYNN 30% Cheaper
  4. What Could Light a Fire Under Costco Wholesale Stock
  5. The Hidden Dangers Facing Amazon.com Stock
  6. Cash Rich, Low Price – Ardent Health Stock to Break Out?

Return Period TRNS S&P 500
1D 0.9% -0.4%
7D (Current Streak) 11.9% -0.5%
1M (21D) 8.4% 0.8%
3M (63D) -0.1% 11.0%
YTD 2025 -13.8% 9.5%
2024 -3.3% 23.3%
2023 54.3% 24.2%
2022 -23.3% -19.4%

 
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has TRNS behaved after prior drops? See TRNS Dip Buyer Analysis to learn more.

Gains and Losses Streaks: S&P 500 Constituents

There are currently 33 S&P constituents with 3 days or more of consecutive gains and 35 constituents with 3 days or more of consecutive losses.
 

Consecutive Days # of Gainers # of Losers
3D 16 29
4D 11 3
5D 3 3
6D 3 0
7D or more 0 0
Total >=3 D 33 35

 
 
Key Financials for Transcat (TRNS)

Last 2 Fiscal Years:

Metric FY2024 FY2025
Revenues $259.5 Mil $278.4 Mil
Operating Income $19.8 Mil $17.9 Mil
Net Income $13.6 Mil $14.5 Mil

Last 2 Fiscal Quarters:

Metric 2025 FQ4 2026 FQ1
Revenues $77.1 Mil $76.4 Mil
Operating Income $6.9 Mil $5.3 Mil
Net Income $4.5 Mil $3.3 Mil

 
While TRNS stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.